Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Ambalal Sarabhai Enterprises Ltd Performance

Today's Low
44.25
arrowIcon
Today's High
47.50
52 Wk Low
20.90
arrowIcon
52 Wk High
70.00


Open

45

Traded Value (Cr)

37.54 L

Prev. Close

45.77

VWAP

46.67

Volume

80,116

Face Value

10

Ambalal Sarabhai Enterprises Ltd Fundamentals

Market Cap
₹ 356 Cr
P/E Ratio (TTM)
122.45
P/B Ratio
2.81
Debt to Equity
0.35
ROE
3.71 %
EPS (TTM)
0.38
Dividend Yield
0.00%
Book Value
16.58

Click here to know more about Fundamentals

Ambalal Sarabhai Enterprises Ltd Financials

Ambalal Sarabhai Enterprises Ltd Financials

Ambalal Sarabhai Enterprises Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 57.92 % 59.46 % 60.76 % 61.54 %
Promoters 30.77 % 30.77 % 30.77 % 30.77 %
Others 11.31 % 9.77 % 8.46 % 7.68 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

57.92%

Promoters

30.77%

Others

11.31%

FII

0.00%

Mutual Funds

0.00%

Retail

59.46%

Promoters

30.77%

Others

9.77%

FII

0.00%

Mutual Funds

0.00%

Retail

60.76%

Promoters

30.77%

Others

8.46%

FII

0.00%

Mutual Funds

0.00%

Retail

61.54%

Promoters

30.77%

Others

7.68%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹46.01

PIVOT

resistance-arrow
Resistance
First Resistance₹49.020
Second Resistance₹51.510
Third Resistance₹54.520
support-arrow
Support
First Resistance₹43.520
Second Resistance₹40.510
Third Resistance₹38.020
RSI42.383
MACD-2.342
ADX13.296
CCI-43.769

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day116,48776,88966.01
Week142,603106,28475.10
1 Month90,33168,27775.99
6 Months000.00

About Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India. During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System. During the year 2010-11, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010. Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019. In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.

Managing Director

Mohal Kartikeya Sarabhai

Founded

1977

NSE Symbol

AMBASARABH

Ambalal Sarabhai Enterprises Ltd Management

NameDesignation
Kartikeya V SarabhaiChairman & Wholetime Director
Ashwin P HathiIndependent Director
Chaula ShastriWhole-time Director
Chandrashekhar B. BohraIndependent Director
Damodar SejpalCompany Sec. & Compli. Officer
Mayur K SwediaIndependent Director
BRIJESH KHANDELWALDirector
Govindprasad NamdeoAdditional Director
Ajay MayorAdditional Director
Bharatendu JaniAdditional Director

Ambalal Sarabhai Enterprises Ltd News

Ambalal Sarabhai Enterprises consolidated net profit declines 60.80% in the December 2023 quarter
Sales rise 21.92% to Rs 43.11 crore
Ambalal Sarabhai Enterprises to conduct board meeting
On 13 February 2024
Ambalal Sarabhai Enterprises consolidated net profit rises 5.88% in the September 2023 quarter
Sales decline 14.58% to Rs 40.01 crore
Ambalal Sarabhai Enterprises to discuss results
On 7 November 2023
Ambalal Sarabhai Enterprises to conduct AGM
On 28 September 2023
Ambalal Sarabhai Enterprises revises board meeting date
To 24 August 2023
Ambalal Sarabhai Enterprises schedules EGM
On 21 September 2023
Ambalal Sarabhai Enterprises to convene board meeting
On 19 August 2023
Ambalal Sarabhai Enterprises reports consolidated net loss of Rs 4.87 crore in the June 2023 quarter
Sales decline 17.30% to Rs 36.10 crore
Ambalal Sarabhai Enterprises to hold board meeting
On 10 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
ADANIENT₹ 3,15,409 Cr
₹ 2,799.20
(1.17 %)
110.94
AEGISCHEM₹ 20,331 Cr
₹ 598.75
(3.37 %)
46.08
CELLO₹ 18,674 Cr
₹ 872.85
(-0.80 %)
491.56
REDINGTON₹ 15,846 Cr
₹ 207.70
(2.47 %)
15.16
HONASA₹ 13,884 Cr
₹ 428.70
(0.12 %)
145.65

Ambalal Sarabhai Enterprises Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Ambalal Sarabhai Enterprises Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Ambalal Sarabhai Enterprises Ltd's share price is ₹46.86 as of May 10, 2024

Ambalal Sarabhai Enterprises Ltd's P/E ratio is 122.45 times as of May 10, 2024.

Ambalal Sarabhai Enterprises Ltd's most recent financial reports indicate a price-to-book ratio of 2.81, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Ambalal Sarabhai Enterprises Ltd's market is 357 Cr as on May 10, 2024.

The current financial records of Ambalal Sarabhai Enterprises Ltd show a 3.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Ambalal Sarabhai Enterprises Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Ambalal Sarabhai Enterprises Ltd's 52-week high and low as of May 10, 2024 are ₹47.5 and ₹44.25 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Ambalal Sarabhai Enterprises Ltd stands at 30.77%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.